Biotech Values

[swampboots]

In my opinion, both complementary and necessary, the misinterpretation of landmark scientific breakthroughs equal immediate engagement and funding, and also equal, exaggerated hopes in a new pill.
Decades of research has speed up these consequences, and this article may provide a tidy example ( replicated in hundreds of other research timetables), of a single aspect of this landscape, zooming in on the real pace ( of human disease benefits) attempting to overcome unknown complexities relating to a single mutation.

"Cancer drugs are closing in on some of the deadliest mutations"

https://www.nature.com/articles/d41586-022-03392-utm_source=Nature+Briefing&utm_campaign=0d6c160cd2-briefing-dy-20221025&utm_medium=email&utm_term=0_c9dfd39373-0d6c160cd2-44970129

Personally I have no objections to these forces of slow progress, only the cautionary aspects valuable to investors.